| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $167.5M | +0.0% |
| R&D Expense | $108.4M | +29.9% |
| SG&A Expense | $34.5M | +30.4% |
| Operating Income | -$142.9M | -348.1% |
| Pre-tax Income | -$131.1M | -345.5% |
| Income Tax | $0 | -100.0% |
| Net Income | -$131.1M | -351.0% |
| EPS (Basic) | -$3.05 | -314.8% |
| EPS (Diluted) | -$3.05 | -344.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $189.2M | -3.8% |
| Short-term Investments | $152.7M | — |
| Current Assets | $349.7M | +73.4% |
| Total Assets | $397.1M | +65.1% |
| Current Liabilities | $22.6M | +9.1% |
| Total Liabilities | $42.2M | -3.4% |
| Stockholders' Equity | $355.0M | +214.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.9M | -247.4% |
| Capital Expenditures | $794K | -30.8% |
| Investing Cash Flow | -$171.0M | — |
| Financing Cash Flow | $275.3M | +196.5% |
| Free Cash Flow | -$112.7M | -250.7% |